FDA Inspection 723214 — Emerald 3 Enterprises, Inc.

Emerald 3 Enterprises, Inc. — FEI 3003314670

The FDA completed an inspection of Emerald 3 Enterprises, Inc. on Apr 19, 2011 in Camdenton, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 20 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 19, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Camdenton, MO (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
136121 CFR 211.100(a)Absence of Written Procedures
139321 CFR 211.103Yield calculations not verified by 2nd person
144821 CFR 211.111Establishment of time limitations
145021 CFR 211.113(a)Procedures for non-sterile drug products
155021 CFR 211.125(f)Procedures Written and Followed
178721 CFR 211.80(a)Procedures To Be in Writing
180121 CFR 211.84(a)Components withheld from use pending release
183321 CFR 211.84(d)(1)Identity Testing of Each Component
188621 CFR 211.165(c)Sampling and testing plans not described
191421 CFR 211.166(a)Lack of written stability program
356221 CFR 211.56(c)Written procedures lacking for use of pesticides etc.
356921 CFR 211.89Quarantine of Rejected Components et. al.
361621 CFR 211.165(d)Acceptance criteria for sampling & testing
430321 CFR 211.67(b)Written procedures fail to include
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
437921 CFR 211.188(b)(1)Dates not included for each significant step
438921 CFR 211.198(a)Procedures to be written and followed
900121 CFR 211.22(a)Lack of quality control unit